September 11, 2017 – The Stem Cell Foundation

Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy

Post author:2by2host
Post published:September 11, 2017
Post category:Articles Stem Cells

Chronic hyperglycemia causes a progressive decrease of β-cell function and mass in type 2 diabetic patients. Growing evidence suggests that augment of autophagy may be an effective approach to protect βcells against…

A Descriptive Study on The Safety and Efficacy of Mesenchymal Stem Cell Therapy For Parkinson’s Disease: A Case Series

Post author:2by2host
Post published:September 11, 2017
Post category:Articles Stem Cells

Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats

Post author:2by2host
Post published:September 11, 2017
Post category:Articles Stem Cells

To explore a novel therapy against Parkinson's disease (PD), we evaluated the therapeutic effects of human bone marrow-derived mesenchymal stem cells (hBM-MSCs), pluripotent stromal cells with secretory potential of various…

An update on stem cell therapy for neurological disorders: cell death pathways as therapeutic targets

Post author:2by2host
Post published:September 11, 2017
Post category:Articles Stem Cells

Here, we compiled ten papers detailing recent strides in the field of stem cell therapy, which address critical issues relevant to pursuing this experimental treatment for clinical applications in brain…